XML 31 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Note 15 - Subsequent Events
6 Months Ended
Jun. 30, 2020
Notes to Financial Statements  
Subsequent Events [Text Block]
15.
Subsequent Events
 
2020
Offering
 
On
July 6, 2020,
Gevo completed a public offering (the “Offering”) of (i)
20,896,666
Series
1
units (the “Series
1
Units”) at a price of
$0.60
per Series
1
Unit, and (ii)
9,103,334
Series
2
units (the “Series
2
Units”) at a price of
$0.59
per Series
2
Unit. The Offering was made under a registration statement on Form S-
1
filed with the Securities and Exchange Commission, declared effective on
June 30, 2020.
 
Each Series
1
Unit consists of
one
share of the Company's common stock and
one
Series
2020
-A warrant to purchase
one
share of the Company's commons stock (each, a “Series
2020
-A Warrant”). Each Series
2
Unit consists of a pre-funded Series
2020
-B warrant to purchase
one
share of the Company's common stock (each, a “Series
2020
-B Warrant” and, together with the Series
2020
-A Warrants, the “Warrants”) and
one
Series
2020
-A Warrant. The Series
2020
-A Warrants are exercisable beginning on the date of original issuance and will expire
five
years from the date of issuance, at an exercise price of
$0.60
per share. The pre-funded Series
2020
-B Warrants are exercisable beginning on the date of issuance at a nominal exercise price of
$0.01
per share of common stock any time until the Series
2020
-B Warrants are exercised in full. In connection with the Offering, the Company issued Series
2020
-A Warrants to purchase an aggregate of
30,000,000
shares of common stock.
 
The net proceeds to the Company from the Offering were approximately
$16.2
million, after deducting placement agent fees and other estimated offering expenses payable by the Company, and
not
including any future proceeds from the exercise of the Warrants. The Company intends to use the net proceeds from the Offering to fund working capital and for other general corporate purposes.
 
Conversion of
2020/21
 Notes
 
On
July 10, 2020,
certain holders of the
2020/21
Notes converted
$2.0
million in aggregate principal amount of
2020/21
Notes (including the conversion of an additional 
$0.3
million for make-whole payment) into an aggregate of 
4,169,428
shares of common stock pursuant to the terms of the
2020/21
Indenture. There was
$12.5
 million principal outstanding for the
2020/21
Notes upon completion of the conversion of the
2020/21
Notes.